Lu, Christine Y <br/><br/>
Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function?  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Aug 2013 
 - 482-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3080 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2013.04.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anthracyclines--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Australia<br/>Breast Neoplasms--drug therapy<br/>Cohort Studies<br/>Female<br/>Heart Diseases--chemically induced<br/>Heart Function Tests--statistics & numerical data<br/>Humans<br/>Logistic Models<br/>Middle Aged<br/>Receptor, ErbB-2--metabolism<br/>Socioeconomic Factors<br/>Taxoids--adverse effects<br/>Trastuzumab<br/>Young Adult